Ultomiris 300 MG/3 ML vial 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26FQS2S
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $27,701
Award facts
- Contract value 100% obligated
- $27,701.19 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ultomiris 300 mg/3 ml vials, a complement-inhibiting monoclonal antibody used in the treatment of certain hemolytic anemias and other complement-mediated disorders. This non-competitive, firm fixed-price delivery order, valued at $27,701.19, is scheduled for completion by January 8, 2026, and represents a continuation of the company's extensive pharmaceutical supply obligations to the federal government. AmerisourceBergen maintains its corporate headquarters in Conshohocken, Pennsylvania, which serves as the place of performance for this order.
This delivery order is issued under AmerisourceBergen's prime Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The larger vehicle serves as a comprehensive global pharmaceutical support contract enabling AmerisourceBergen to supply an extensive range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. The contract facilitates medical supply chain operations for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems, positioning AmerisourceBergen as a critical vendor within the Department of Defense's pharmaceutical procurement infrastructure.
Quick answers
Who was awarded contract SPE2DR26FQS2S?
SPE2DR26FQS2S was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 16, 2025.
How much is contract SPE2DR26FQS2S worth?
The government has obligated $27,701 on SPE2DR26FQS2S.
Is contract SPE2DR26FQS2S an order under another contract?
Yes. SPE2DR26FQS2S is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQS2S competed?
The extent of competition for SPE2DR26FQS2S was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award